These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1363672)

  • 21. [Beta blockers, fibrinogen, and atherosclerosis].
    Serrano Aguilar PG
    Med Clin (Barc); 1994 Feb; 102(6):231-5. PubMed ID: 7909001
    [No Abstract]   [Full Text] [Related]  

  • 22. Prazosin: a review of clinical experience in hypertension.
    Packard RS
    Ther Umsch; 1981; 38 Suppl():28-32. PubMed ID: 6122285
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute influence of beta-adrenergic antagonists on left ventricular diastolic function: contrasting results after administration of celiprolol and metoprolol.
    Modersohn D; Franz N; Heublein B; Panzner B; Walde T; Bruch L
    J Hum Hypertens; 1994 Feb; 8(2):127-32. PubMed ID: 7911530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of long-term fenbutol therapy on lipid metabolism in patients with ischemic heart disease].
    Lupanov VP; Liakishev AA; Tvorogova MG; Titov VN; Kukharchuk VV
    Kardiologiia; 1993; 33(4):19-22. PubMed ID: 7933784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the influence of celiprolol, metoprolol and atenolol on pulmonary ventilation in patients with asthma].
    Szmidt M; Minc P; Wasiak W
    Pneumonol Alergol Pol; 1999; 67(9-10):452-61. PubMed ID: 10808389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A vasodilating β1 blocker celiprolol inhibits muscular release of uric acid precursor in patients with essential hypertension.
    Mizuta E; Utami SB; Ohtahara A; Endo S; Mishima M; Hasegawa A; Yamada K; Kato M; Yamamoto K; Ogino K; Ninomiya H; Miyazaki S; Hamada T; Taniguchi SI; Cheng J; Hisatome I
    Horm Metab Res; 2013 Jan; 45(1):69-73. PubMed ID: 22893261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
    Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of celiprolol and chlorthalidone in hypertensive patients with reversible airways obstruction.
    Capone P; Mayol R; Mathieu M
    Br J Clin Pract Suppl; 1985 Jun; 40():37-9. PubMed ID: 2864061
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celiprolol pneumonitis.
    Lombard JN; Bonnotte B; Maynadie M; Foucher P; Reybet Degat O; Jeannin L; Camus P
    Eur Respir J; 1993 Apr; 6(4):588-91. PubMed ID: 8098286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E; Rosenthal T; Goldbourt U; Segal P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The rational selection of beta-blockers in the treatment of hypertension].
    Ter Arkh; 1999; 71(2):57-64. PubMed ID: 10222557
    [No Abstract]   [Full Text] [Related]  

  • 33. β-blockers for COPD inpatients.
    Suissa S; Ernst P
    Thorax; 2012 Nov; 67(11):936-7. PubMed ID: 23100217
    [No Abstract]   [Full Text] [Related]  

  • 34. [Physiotherapy in correction of proatherogenic shifts in long-term administration of beta-blockers and thiazide diuretics].
    Razumov AN; Kniazeva TA; Badtieva VA
    Vopr Kurortol Fizioter Lech Fiz Kult; 2002; (6):3-5. PubMed ID: 12592894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celiprolol, clinical dosage, efficacy and safety in asthmatic and elderly patients.
    Hitzenberger G
    Br J Clin Pract Suppl; 1985 Jun; 40():25-32. PubMed ID: 2864058
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in serum lipids during drug therapy of hypertension].
    Lohmann FW
    Wien Med Wochenschr; 1982; 132 Spec No 2():6-14. PubMed ID: 6132498
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pathogenetic approaches to the differentiated drug therapy of hypertension].
    Malaia LT; Vasyl'iev IuM; Babadzhan VD; Koval' SN
    Lik Sprava; 1997; (3):47-51. PubMed ID: 9377352
    [No Abstract]   [Full Text] [Related]  

  • 38. Expert consensus document on beta-adrenergic receptor blockers.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(15):1341-62. PubMed ID: 15288162
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of Celiprolol and Bisoprolol on Blood Pressure, Vascular Stiffness, and Baroreflex Sensitivity.
    Eguchi K; Hoshide S; Kario K
    Am J Hypertens; 2015 Jul; 28(7):858-67. PubMed ID: 25577782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The correction of the hemodynamic disorders in patients with IHD complicated by intraventricular blocks by using beta-adrenergic agents].
    V'iuchnova ES; Maev IV; Merzlikin LA
    Ter Arkh; 1995; 67(2):54-7. PubMed ID: 7725262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.